Sign in
4

Changes in Ownership

GUIDED THERAPEUTICS INC Filed Acc 0001477932-26-001320

Director acquired 664,266 shares (conversion)

  • Director disposed of 100 shares (other)
  • Director acquired 425,338 shares (other)
  • Director acquired 500,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Imhoff John E · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-18 Conversion : show line 1 in the form +195,460 $0.07 $13,682 19,658,955 D
2026-01-05 Other acquisition : show line 2 in the form +25,338 19,684,293 D
2026-02-02 Conversion : show line 3 in the form +312,720 $0.07 $21,890 19,997,013 D
2026-02-25 Option exercise : show line 4 in the form +500,000 20,497,013 D
2026-02-27 Other disposition : show line 5 in the form −100 0 D
2026-02-27 Other acquisition : show line 6 in the form +400,000 20,897,013 D
2026-02-27 Conversion : show line 7 in the form +156,086 $0.07 $10,926 21,053,099 D

Table II: Derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-18 Conversion : show line 8 in the form Convertible Promissory Note −195,460 150,000 D
2026-02-02 Conversion : show line 9 in the form Convertible Promissory Note −312,720 130,000 D
2026-02-25 Other disposition : show line 10 in the form Warrants −500,000 0 D
2026-02-25 Other acquisition : show line 11 in the form Warrants +500,000 500,000 D
2026-02-25 Other disposition : show line 12 in the form Warrants −500,000 0 D
2026-02-25 Other acquisition : show line 13 in the form Warrants +500,000 500,000 D
2026-02-25 Option exercise : show line 14 in the form Warrants −500,000 0 D
2026-02-27 Conversion : show line 15 in the form Convertible Promissory Note −156,086 $0.07 $10,926 120,000 D
Loading xslF345X05/form4.xml…